Replies to post #25716 on Endonovo Therapeutics Inc (ENDV)

[Biotech_Tradez]

They did not pay $1 million for it. No cash or stock was ever exchanged for it. It is still mentioned because IPR is still a subsidiary so they have to report it, but they are not in that business anymore.